Sean Mateer
About Sean Mateer
Sean Mateer is a Validation Engineer currently working at Wuxi Biologics, Alexion Pharmaceuticals, and Bristol-Myers Squibb, with extensive experience in upstream bioprocessing and GMP implementation.
Title
Sean Mateer holds the title of Validation Engineer. He is currently serving in this capacity at three different organizations: Wuxi Biologics, Alexion Pharmaceuticals, Inc., and Bristol-Myers Squibb.
Company
Sean Mateer is employed at Wuxi Biologics as Upstream Cqv Lead in Wuxi, Jiangsu, China. He also works at Alexion Pharmaceuticals Inc. as a Cqv Engineer in Boston, Massachusetts, United States, and at Bristol-Myers Squibb as a Validation Engineer in New Jersey, United States.
Education and Expertise
Sean Mateer achieved a Doctor of Philosophy degree from the University of Newcastle, where he focused on Philosophy during his studies from 2012 to 2015. He also holds a Bachelor of Science degree in Biotechnology from Dublin City University. His expertise includes upstream bioprocessing, cell culture, fermentation processes, and the implementation of Good Manufacturing Practices (GMP) in biopharmaceutical production environments.
Background
Sean Mateer has a diverse work history spanning several continents and roles. He worked at Hunter Medical Research Institute (HMRI) as an Instrumentation Engineer in Australia from 2015 to 2016. He was a Ph.D. Candidate and Researcher at the University of Newcastle from 2012 to 2015. Additionally, he served as a Pharmacovigilance Specialist at Iqvia in Durham, North Carolina, United States, for 8 months in 2011.
Achievements
Sean Mateer led the upstream commissioning, qualification, and validation (CQV) efforts for biopharmaceutical manufacturing processes at Wuxi Biologics. He has contributed significantly to the successful scale-up of biopharmaceutical production processes from laboratory to commercial scale. His participation in cross-functional teams ensured compliance with regulatory standards in biopharmaceutical manufacturing.